As mentioned above, the design of the Enamine screening collection took into consideration drug-and lead-likeness concepts prevalent in drug discovery in the 2000s and partiallyin 2010s, focusing on generating high-quality hits. As such, the molecule sizes and complexities are in the lower ranges (fig. ), enabling modification and decoration of identified hits and also allowing for molecular weight increase during hit to lead and lead optimization programs.